FGF-23: payments to doctors
Payments that named FGF-23 as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
Was your doctor paid by Quidel Corporation?
Quidel Corporation reported the most payments naming FGF-23. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $25K
- Providers
- 1
- Transactions
- 2
- Average per transaction
- $12,705
The per-transaction average — $12,705 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1 providers the average total is $25,411, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Quidel Corporation | $25,411 | 100.0% |
Other products from Quidel Corporation
The company that reported the most payments naming FGF-23 also reports against these.
- Eye Health$499,041
- H&V-Mix$104,531
- R-Mix$104,531
- Super E-Mix$104,531
- InflammaDry$51,104
- MicroVue Bone$31,977
- TBI$27,702
- TSI$26,981
- Solana$15,980
- Sofia$15,675